Kazia Therapeutics (KZIA) Dividends payables (2013)
Kazia Therapeutics (KZIA) posted Dividends payables of -$22985.3 billion for Q4 2013.
Kazia Therapeutics (KZIA) Dividends payables (2013) Analysis & Trends
Kazia Therapeutics' Dividends payables history runs 1 years deep, the most recent figure standing at -$22985.3 billion for Q4 2013.
- Quarterly Dividends payables changed N/A year-over-year to -$22985.3 billion in Q4 2013, while the trailing twelve-month figure through Dec 2013 was -$22985.3 billion (changed N/A YoY) and the FY2013 annual result came in at -$24002.8 billion, changed N/A from the prior year.
- Dividends payables was -$22985.3 billion for Q4 2013 at Kazia Therapeutics.
- Across five years, Dividends payables topped out at -$22985.3 billion in Q4 2013 and bottomed at -$22985.3 billion in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -22,985.27 Bn |